RecruitingNCT06271291

Pancreatic Cancer Detection Consortium (PCDC) Prospective Cohorts

Sponsor

Mayo Clinic

Enrollment

30,000 participants

Start Date

Dec 12, 2024

Study Type

OBSERVATIONAL

Conditions

Pancreatic Carcinoma

Summary

This study evaluates individuals without pancreatic cancer, but who have been determined to be at higher-than-average lifetime risk of developing pancreatic cancer to help detect pancreatic cancer or other cancers at an earlier time when they might be more easily treated and cured.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study is building a database of people at high risk for pancreatic cancer — either due to family history or genetic mutations — to improve early detection methods. Participants will undergo regular screening tests over time. **You may be eligible if...** - You are 50 or older - You have two or more close relatives diagnosed with pancreatic cancer - You carry certain genetic mutations linked to pancreatic cancer (such as CDKN2A, STK11, BRCA1/2, or others) - You have no current diagnosis of pancreatic cancer **You may NOT be eligible if...** - You have already been diagnosed with pancreatic cancer - You have had your pancreas completely removed - You do not meet the family history or genetic criteria Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.